Lentinan Properties in Anticancer Therapy: A Review on the Last 12-Year Literature
Luca Vannucci1, Petr Sima1, Vaclav Vetvicka2 & Jiri Krizan1 Show affiliations
- Institute of Microbiology v.v.i., Czech Academy of Sciences, Czech Republic
- University of Louisville, United States
American Journal of Immunology, Volume 13, Issue 1, pp. 50–61 · doi.org/10.3844/ajisp.2017.50.61
Abstract
The effects of β-glucan in cancer are the most studied biological effects of β-glucan. From all available β-glucans, the most data are available on lentinan, mostly because it is used in clinical practice for over 20 years. Current review represent a state-of-the-art comprehensive review of knowledge obtained in last twelve years.
Licence and reuse
Open access. This article is licensed under a Creative Commons Attribution 3.0 Licence (CC BY 3.0), as printed on the article, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original authors and the source. No permission is needed.
How to reuse this articleResponses (0)
About this article
Vannucci, L., Sima, P., Vetvicka, V. & Krizan, J. (2017). Lentinan Properties in Anticancer Therapy: A Review on the Last 12-Year Literature. American Journal of Immunology, 13(1), 50–61. https://doi.org/10.3844/ajisp.2017.50.61
- Licence
- CC BY 3.0
- Issue
- Volume 13, Issue 1
- Policies
- Editorial independenceUse of generative AIData availabilityAppeals and complaints
- Version
- Version of record